Hastings Cent Rep. 2021 Nov;51 Suppl 2:S42-S47. doi: 10.1002/hast.1319.
The release of genetically engineered organisms into the shared environment raises scientific, ethical, and societal issues. Using some form of democratic deliberation to provide the public with a voice on the policies that govern these technologies is important, but there has not been enough attention to how we should connect public deliberation to the existing regulatory process. Drawing on lessons from previous public deliberative efforts by U.S. federal agencies, we identify several practical issues that will need to be addressed if relevant federal agencies are to undertake public deliberative activities to inform decision-making about gene editing in the wild. We argue that, while agencies may have institutional capacity to undertake public deliberative activities, there may not be sufficient political support for them to do so. Advocates of public deliberation need to make a stronger case to Congress about why federal agencies should be encouraged and supported to conduct public deliberations.
将基因工程生物释放到共享环境中引发了科学、伦理和社会问题。利用某种形式的民主审议,让公众对管理这些技术的政策有发言权是很重要的,但我们还没有足够重视如何将公众审议与现有的监管过程联系起来。借鉴美国联邦机构以前进行公众审议的经验教训,我们确定了相关联邦机构如果要开展公众审议活动,为野生基因编辑的决策提供信息,需要解决的几个实际问题。我们认为,虽然机构可能有机构能力来开展公众审议活动,但可能没有足够的政治支持来这样做。公众审议的倡导者需要向国会提出更有力的理由,说明为什么应该鼓励和支持联邦机构进行公众审议。